Posted on 10/30/19
Press Ganey Named One of the “Fastest Growing Firms” by Consulting Magazine
BOSTON--(BUSINESS WIRE)--Press Ganey today announced that it has been recognized by Consulting magazine as one of the “Fastest Growing Firms” in the United States for the . . .
Posted on 10/29/19
Vertex Pharmaceuticals Gains FDA Approval for Cystic Fibrosis Drug
Vertex Pharmaceuticals (NASDAQ:VRTX) made news last week when its long-anticipated cystic fibrosis treatment, Trikafta, received approval from the U.S. Food and Drug Administration (FDA). While this . . .
Posted on 10/28/19
Gilead and Glympse Bio Announce Strategic Collaboration
FOSTER CITY, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gilead Sciences Inc. (Nasdaq: GILD) and Glympse Bio, Inc., today announced that the companies have entered into a strategic collaboration . . .
Posted on 10/28/19
BASF and Greentown Labs Announce Startup Finalists in the Circularity Challenge
BASF, one of the world's leading chemical companies, and Greentown Labs, the largest cleantech incubator in North America, have selected five startups for their Circularity Challenge, . . .
Posted on 10/28/19
Better Buy: Illumina vs. Thermo Fisher Scientific
If you're looking to invest in gene sequencing, Illumina (NASDAQ:ILMN) and Thermo Fisher Scientific (NYSE:TMO) are the two top options based on size. These two companies . . .
Posted on 10/25/19
Biogen Aducanumab Reversal Is Stunning, But Don't Expect A Repeat For Other Alzheimer's Drugs
SummaryBiogen’s Alzheimer’s drug aducanumab was brought back from the dead after new data collected showed efficacy in slowing cognitive impairment.Investors may start chasing other failed beta . . .
Posted on 10/24/19
Alnylam Named #1 Biopharma Employer by Science Magazine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that Science magazine has named the company the world’s number one employer . . .
Posted on 10/24/19
Moderna Named Top Employer by Science for Fifth Consecutive Year
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines . . .
Posted on 10/24/19
Genocea Provides Corporate Update and Reports Third Quarter 2019 Financial Results
CAMBRIDGE, Mass., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today reported its operating and financial . . .
Posted on 10/24/19
Biogen: A Trading Strategy
SummaryBIIB surprised the Street with news that it plans to file a BLA for aducanumab, or adu, in Q1 2020.Separately, BIIB reported upside EPS surprise for . . .
Posted on 10/24/19
Thermo Fisher Scientific: Firming Profitability And Improving Balance Sheet
SummaryTMO reported Q3 earnings which beat expectations and showed a continuation of firming profitability with a positive outlook.Company is building momentum from a number of acquisitions . . .
Posted on 10/24/19
Is Biogen a Buy After the Biggest Biotech Bombshell in Years?
Biogen (NASDAQ:BIIB) has been a bust for much of 2019. The stock plunged in March after the company halted two late-stage clinical studies evaluating aducanumab in . . .
Posted on 10/24/19
Here's Why Biogen's Big Gain Won't Last Long
Millions of Alzheimer's disease patients, their families, and their friends felt their hearts sink when Biogen (NASDAQ:BIIB) broke the bad news that an experimental Alzheimer's therapy, . . .
Posted on 10/24/19
Biogen's Stock Could More Than Quadruple in Value in 5 Years
Biogen's (NASDAQ:BIIB) stock caught fire yesterday. Although the biotech posted stellar third-quarter results that surpassed analysts' expectations ahead of the opening bell on Tuesday, the real . . .
Posted on 10/24/19
ConvenientMD and North Country Healthcare Announce Partnership
ConvenientMD, a leading provider of urgent care and walk-in medical services in New Hampshire, Maine, and Massachusetts, and North Country Healthcare, a leading network of critical . . .
Posted on 10/23/19
Charles River Laboratories Closes Senior Notes Offering
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has closed its previously announced offering of $500 million in aggregate principal amount . . .
Posted on 10/23/19
Colangelo Adds Vireo Health to Client Roster
Medical Cannabis Company Taps Colangelo’s Occasion-Based Approach to Launch First Recreational Brand. Colangelo, the marketing agency focused on Brand Attachment, announced today that it has been . . .
Posted on 10/23/19
Boston Mutual Life Insurance Establishes New Enterprise Risk Management Department
Boston Mutual Life Insurance Company, a national provider of insurance solutions for individuals and at the workplace, announced the introduction of its new Enterprise Risk Management . . .
Posted on 10/23/19
Boston Scientific Announces Results For Third Quarter 2019
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.707 billion during the third quarter of 2019. This represents growth of 13.1 percent on a reported basis, . . .
Posted on 10/23/19
Thermo Fisher Scientific Reports Third Quarter 2019 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 28, 2019.Third Quarter . . .
Posted on 10/23/19
Alexion Reports Third Quarter 2019 Results
BOSTON--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced financial results for the third quarter of 2019. Total revenues in the third quarter were $1,263.1 million, a 23 . . .
Posted on 10/23/19
Biogen Inc. (BIIB) CEO Michel Vounatsos on Q3 2019 Results - Earnings Call Transcript
Biogen Inc. (NASDAQ:BIIB) Q3 2019 Earnings Conference Call October 22, 2019 8:00 AM ETCompany ParticipantsJoe Mara - Vice President, Investor RelationsMichel Vounatsos - Chief Executive OfficerAl . . .
Posted on 10/23/19
Why Biogen Stock Is on Fire Today
What happenedBiotech heavyweight Biogen (NASDAQ:BIIB) saw its shares rise by as much as 43.7% in premarket trading Tuesday morning. The biotech's stock caught fire in early . . .
Posted on 10/22/19
Bicycle Therapeutics Expands Neuroscience Collaborations
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide . . .
Posted on 10/22/19
Boston Scientific Announces Cash Tender Offer for Up To $1.0 Billion of Its Outstanding Debt Securities
Boston Scientific Corporation (NYSE:BSX) today announced the commencement of a cash tender offer for up to $1.0 billion aggregate principal amount of the outstanding senior notes . . .

